Icon

ACTIQ (nda020747)- (EQ 0.2MG BASE,EQ 0.4MG BASE,EQ 0.6MG BASE,EQ 0.8MG BASE,EQ 1.2MG BASE,EQ 1.6MG BASE)

FENTANYL CITRATE CEPHALON
EQ 0.2MG BASE,EQ 0.4MG BASE,EQ 0.6MG BASE,EQ 0.8MG BASE,EQ 1.2MG BASE,EQ 1.6MG BASE
Yes No
2006-Sep-05 Expired
None None
None No
Actiq is indicated on ly for the management of breakthrough cancer pain in patients with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
1 0 1
Total Other Developers None
Drugs with Suitability No
EQ 0.2MG BASE ** ** - - -
EQ 0.4MG BASE ** ** - - -
EQ 0.6MG BASE ** ** - - -
EQ 0.8MG BASE ** ** - - -
EQ 1.2MG BASE ** ** - - -
EQ 1.6MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.